APA

Udvardy M., Schwartzott D., Jackson K. & McKee P. A. (19950731). Hybrid peptide containing RGDF (Arg-Gly-Asp-Phe) coupled with the carboxy terminal part of alpha 2-antiplasmin capable of inhibiting platelet aggregation and promoting fibrinolysis. : Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Chicago

Udvardy M, Schwartzott D, Jackson K and McKee P A. 19950731. Hybrid peptide containing RGDF (Arg-Gly-Asp-Phe) coupled with the carboxy terminal part of alpha 2-antiplasmin capable of inhibiting platelet aggregation and promoting fibrinolysis. : Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Harvard

Udvardy M., Schwartzott D., Jackson K. and McKee P. A. (19950731). Hybrid peptide containing RGDF (Arg-Gly-Asp-Phe) coupled with the carboxy terminal part of alpha 2-antiplasmin capable of inhibiting platelet aggregation and promoting fibrinolysis. : Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

MLA

Udvardy M, Schwartzott D, Jackson K and McKee P A. Hybrid peptide containing RGDF (Arg-Gly-Asp-Phe) coupled with the carboxy terminal part of alpha 2-antiplasmin capable of inhibiting platelet aggregation and promoting fibrinolysis. : Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis. 19950731.